Fidelity Select Pharmaceuticals Portfolio (FPHAX)
31.32
+0.33
(+1.06%)
USD |
May 19 2026
FPHAX Asset Allocations & Exposures
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | 2.19% |
| Stock | 93.39% |
| Bond | 3.40% |
| Convertible | 0.00% |
| Preferred | 0.56% |
| Other | 0.45% |
Market Capitalization
As of March 31, 2026
| Large | 74.53% |
| Mid | 6.91% |
| Small | 18.56% |
Region Exposure
| Americas | 66.63% |
|---|---|
|
North America
|
66.63% |
| Canada | 0.94% |
| United States | 65.69% |
|
Latin America
|
0.00% |
As of March 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 29.76% |
|---|---|
| United Kingdom | 14.56% |
|
Europe Developed
|
15.19% |
| Belgium | 5.10% |
| Denmark | 0.40% |
| Germany | 1.08% |
| Ireland | 3.28% |
| Netherlands | 0.21% |
| Sweden | 0.51% |
| Switzerland | 4.62% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 3.61% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
93.49% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
93.49% |
| Utilities |
|
0.00% |
| Not Classified |
|
6.51% |
| Non Classified Equity |
|
0.92% |
| Not Classified - Non Equity |
|
5.59% |
As of March 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |